Answers are grounded in this paper and cite their sources.
Novel analogues of dexrazoxane suggest that targeting Topoisomerase II beta may be a promising strategy for cardioprotection against anthracycline toxicity.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Jirkovská et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: